Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,38 USD | -6,76% | -10,18% | +25,70% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 57,79 mln. 53,91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,46 mln. | Nettowinst (verlies) 2025 * | -28 mln. -26,12 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,65
x | K/w-verhouding 2025 * |
-2,86
x | Werknemers | 21 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,94% |
Recentste transcriptie over Lantern Pharma Inc.
1 dag | -6,76% | ||
1 week | -10,18% | ||
Lopende maand | -38,86% | ||
1 maand | -49,48% | ||
3 maanden | +27,76% | ||
6 maanden | +89,44% | ||
Lopend jaar | +25,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 01-07-18 |
David Margrave
DFI | Director of Finance/CFO | 64 | 01-06-18 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 02-03-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 01-07-18 |
Director/Board Member | 73 | 08-06-22 | |
Donald Keyser
CHM | Chairman | 71 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 5,38 | -6,76% | 97 934 |
23-04-24 | 5,77 | +0,87% | 127 436 |
22-04-24 | 5,72 | +7,12% | 255 410 |
19-04-24 | 5,34 | -7,45% | 237 791 |
18-04-24 | 5,77 | -3,67% | 107 146 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,70% | 57,79 mln. | |
+4,09% | 43,84 mld. | |
+46,73% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |